The relationship between Activin A and anti-angiogenic factors in the development of pre-eclampsia

Seshini Gurusinghe1, Euan M. Wallace1,2, Rebecca Lim1,2
1The Ritchie Centre, Monash Institute of Medical Research, Monash University, Clayton, Victoria 3168, Australia
2Department of Obstetrics and Gynecology, Monash University, Australia

Tài liệu tham khảo

Conrad, 1998, Circulating levels of immunoreactive cytokines in women with preeclampsia, Am J Reprod Immunol, 40, 102, 10.1111/j.1600-0897.1998.tb00398.x Maynard, 2003, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, J Clin Invest, 111, 649, 10.1172/JCI17189 Venkatesha, 2006, Soluble endoglin contributes to the pathogenesis of preeclampsia, Nat Med, 12, 642, 10.1038/nm1429 Levine, 2006, Soluble endoglin and other circulating antiangiogenic factors in preeclampsia, N Engl J Med, 355, 992, 10.1056/NEJMoa055352 Reddy, 2009, Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia, PLoS ONE, 4, e4453, 10.1371/journal.pone.0004453 Qu, 1995, Inhibin and activin production in human placenta, Endocr Rev, 16, 485, 10.1210/edrv-16-4-485 Fowler, 1998, A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy, Hum Reprod, 13, 3530, 10.1093/humrep/13.12.3530 Muttukrishna, 1997, Activin A and inhibin A as possible endocrine markers for pre-eclampsia, Lancet, 349, 1285, 10.1016/S0140-6736(96)09264-1 D’Antona, 2000, Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders, J Endocrinol, 165, 157, 10.1677/joe.0.1650157 Keelan, 2002, Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies, Obstet Gynecol, 99, 267, 10.1016/S0029-7844(01)01674-X Bersinger, 2003, Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin, Hypertens Pregnancy, 22, 45, 10.1081/PRG-120016794 Casagrandi, 2003, Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the placental tissue of patients with pre-eclampsia, Mol Hum Reprod, 9, 199, 10.1093/molehr/gag029 Silver, 2002, Mechanism of increased maternal serum total activin A and inhibin A in preeclampsia, J Soc Gynecol Invest, 9, 308, 10.1016/S1071-5576(02)00165-X Bersinger, 2002, Pregnancy-associated and placental proteins in the placental tissue of normal pregnant women and patients with pre-eclampsia at term, Eur J Endocrinol, 147, 785, 10.1530/eje.0.1470785 Mandang, 2007, Oxidative stress increases placental and endothelial cell activin A secretion, J Endocrinol, 192, 485, 10.1677/JOE-06-0061 Zhou, 2011, Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia, J Immunol, 186, 6024, 10.4049/jimmunol.1004026 Keelan, 1998, Regulation of activin-A production by human amnion, decidua and placenta in vitro by pro-inflammatory cytokines, Placenta, 19, 429, 10.1016/S0143-4004(98)90084-4